XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements Of Operations And Comprehensive Loss - USD ($)
shares in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
Revenues $ 0 $ 574,000 $ 709,000 $ 574,000
Cost and expenses:        
Cost of revenues 8,400,000 727,000 10,653,000 727,000
Research and development 4,517,000 6,460,000 16,744,000 22,982,000
Sales and marketing 2,020,000 3,404,000 11,251,000 10,697,000
General and administrative 3,088,000 4,256,000 11,373,000 13,772,000
Total costs and expenses 18,025,000 14,847,000 50,021,000 48,178,000
Loss from operations (18,025,000) (14,273,000) (49,312,000) (47,604,000)
Other income (expense):        
Interest income (expense), net (14,000) (9,000) 4,000 (640,000)
Total other income (expense) (14,000) (9,000) 4,000 (640,000)
Net loss (18,039,000) (14,282,000) (49,308,000) (48,244,000)
Other comprehensive gain (loss):        
Unrealized gain on available-for-sale securities       1,000
Comprehensive loss $ (18,039,000) $ (14,282,000) $ (49,308,000) $ (48,243,000)
Net loss per share:        
Basic net loss per share $ (0.49) $ (0.48) $ (1.50) $ (1.76)
Diluted net loss per share $ (0.49) $ (0.48) $ (1.50) $ (1.76)
Weighted average shares used to compute net loss per common share — basic 37,158 29,612 32,825 27,400
Weighted average shares used to compute net loss per common share — diluted 37,158 29,612 32,825 27,400
Product [Member]        
Revenues:        
Revenues   $ 574,000 $ 709,000 $ 574,000